References
- Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–951.
- Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8:687–693.
- Ballouz T, Aridi J, Afif C, et al. Risk factors, clinical presentation, and outcome of Acinetobacter baumannii bacteremia. Front Cell Infect Microbiol. 2017;7:156.
- García-Quintanilla M, Pulido MR, López-Rojas R, et al. Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol. 2013;21:157–163.
- McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013;37:130–155.
- Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.
- Dahdouh E, Gomez-Gil R, Pacho S, et al. Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital. PLoS One. 2017;12:e0176824.
- Shirazi AS, Shafiei M, Solgi H, et al. Different virulence capabilities and ompA expressions in ST2 and ST513 of multidrug-resistant Acinetobacter baumannii. Curr Microbiol. 2019;76:723–731.
- Sahl JW, Johnson JK, Harris AD, et al. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics. 2011;12:291.
- Álvarez-Marín R, López-Rojas R, Márquez JA, et al. Colistin dosage without loading dose is efficacious when treating carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia caused by strains with high susceptibility to colistin. PLoS One. 2016;11:e0168468.
- Nurk S, Bankevich A, Antipov D, et al. Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J Comput Biol. 2013;20:714–737.
- Hyatt D, Chen GL, Locascio PF, et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics. 2010;11:119.
- Casimiro-Soriguer CS, Muñóz-Mérida A, Pérez-Pulido AJ. Sma3s: a universal tool for easy functional annotation of proteomes and transcriptomes. Proteomics. 2017;17:1700071.
- Larsen MV, Cosentino S, Rasmussen S, et al. Multilocus sequence typing of total genome sequenced bacteria. J Clin Microbiol. 2012;50:1355–1361.
- Zankari E, Hasman H, Cosentino S, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67:2640–2644.
- Camacho C, Coulouris G, Avagyan V, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421.
- Siguier P, Perochon J, Lestrade L, et al. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(Database issue):D32–6.
- Chen L, Yang J, Yu J, et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res. 2005;33:D325–8.
- Huang Y, Niu B, Gao Y, et al. CD-HIT suite: a web server for clustering and comparing biological sequences. Bioinformatics. 2010;26:680–682.
- Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2017;20:1160–1166.
- Mussi MA, Limansky AS, Relling V, et al. Horizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channel. J Bacteriol. 2011;193:4736–4748.
- Waterhouse AM, Procter JB, Martin DM, et al. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–1191.
- Smani Y, McConnell MJ, Pachon J. Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells. PLoS One. 2012;7:e33073.
- Amigo N, Zhang Q, Amadio A, et al. Overexpressed proteins in hypervirulent clade 8 and clade 6 strains of Escherichia coli O157: H7compared to E. coli O157: H7EDL933 clade 3 strain. PLoS One. 2016;11:e0166883.
- Mussi MA, Limansky AS, Viale AM. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins. Antimicrob Agents Chemother. 2005;49:1432–1440.
- Smani Y, Dominguez-Herrera J, Pachón J. Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. J Infect Dis. 2013;208:1561–1570.
- Gil-Marqués ML, Pachón-Ibáñez ME, Pachón J, et al. Effect of hypoxia on the pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa in vitro and in murine experimental models of infection. Infect Immun. 2018;86:e00543–18.
- Karah N, Sundsfjord A, Towner K, et al. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 2012;15:237–247.
- Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev. 2014;27:241–263.
- De Gregorio E, Del Franco M, Martinucci M, et al. Biofilm-associated proteins: news from Acinetobacter. BMC Genomics. 2015;16:933.
- Zahn M, D’Agostino T, Eren E, et al. Small-molecule transport by CarO, an abundant eight-stranded beta-barrel outer membrane protein from Acinetobacter baumannii. J Mol Biol. 2015;427:2329–2339.
- Mussi MA, Relling VM, Limansky AS, et al. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett. 2007;581:5573–5578.
- Sánchez-Encinales V, Álvarez-Marín R, Pachón-Ibáñez ME, et al. Overproduction of outer membrane protein A by Acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase. J Infect Dis. 2017;215:966–974.
- Nwugo CC, Gaddy JA, Zimbler DL, et al. Deciphering the iron response in Acinetobacter baumannii: a proteomics approach. J Proteomics. 2011;74:44–58.
- Cabral MP, Soares NC, Aranda J, et al. Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J Proteome Res. 2011;10:3399–3417.
- Marti S, Nait Chabane Y, Alexandre S, et al. Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors. PLoS One. 2011;6:e26030.
- Fernández-Cuenca F, Smani Y, Gómez-Sánchez MC, et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. Int J Antimicrob Agents. 2011;38:548–549.
- Zhang L, Liang W, Xu SG, et al. CarO promotes adhesion and colonization of Acinetobacter baumannii through inhibiting NF-кB pathways. Int J Clin Exp Med. 2019;12:2518–2524.
- López-Rojas R, Smani Y, Pachón J. Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors. Expert Rev Anti Infect Ther. 2013;11:231–233.
- Vila-Farrés X, Parra-Millán R, Sánchez-Encinales V, et al. Combating virulence of gram-negative bacilli by OmpA inhibition. Sci Rep. 2017;7:14683.
- Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discovery. 2013;12:963.
- Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discovery. 2010;9:117–128.
- Parra-Millán R, Vila-Farrés X, Ayerbe-Algaba R, et al. Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy. J Antimicrob Chemother. 2018;73:3405–3412.
- Viale AM, Evans BA. Microevolution in the major outer membrane protein OmpA of Acinetobacter baumannii. Microb Genom. 2020;6(6):e000381.